RPRX Stock Ownership Activity
ROYALTY PHARMA PLC- CL A 13F holders
No value investing guru has made any change to the ROYALTY PHARMA PLC- CL A (RPRX) position according to the gurus' latest SEC quarterly report(s).
Which gurus or hedge funds are buying RPRX now?
According to the latest SEC filing(s) ROYALTY PHARMA PLC- CL A (RPRX) has not been purchased by any super investor.
To see more about who is investing in ROYALTY PHARMA PLC- CL A (RPRX), please go to the RPRX ownership page.
2024 Q3
(1 result)
Current price: $32.89
13.30%
Reported price*: $29.03
2024 Q1
(1 result)
Current price: $32.89
8.40%
Reported price*: $30.34
2023 Q2
(1 result)
Current price: $32.89
6.99%
Reported price*: $30.74
3 of 3
Shares, change to shares, sold shares - split-adjusted.
Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.
Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.